GMOV vs SEIV

GMOVBGMO US Value ETF

SEIVASEI QiM U.S. Large Cap Value Active ETF

In short

GMOV GMO's quant value playbook in an ETF wrapper: proprietary models and relative valuation analysis picking US stocks, priced below the typical active value fund. Launched in late 2024, so the live record is still short.

SEIV Active quant value stock-picking at an index-fund price. SEIV screens U.S. large caps for cheap valuations plus quality, momentum and low volatility, then runs a concentrated book of roughly 80 names for 0.15% a year.

Stated mandate

GMOV The Fund seeks total return through an actively managed strategy focused primarily on U.S. equities. GMO applies proprietary quantitative methods and relative valuation analysis to select securities it believes have attractive return potential.

SEIV The Fund seeks long-term capital appreciation through primarily U.S. common stocks priced below fundamental valuation measures, using a quantitative, active stock-selection approach.

Why people hold it

• GMOV Genuinely active, not an index in disguise: GMO uses proprietary quantitative methods and relative valuation to pick US equities it sees as attractively priced.
• At 0.50%, it undercuts the median fee in its active US value cohort, which is unusual for a boutique manager's first-generation ETF.
• Sits in the upper half of dozens of active US value ETFs, with one of the milder risk profiles measured in the group.
• Pays on a quarterly schedule, the standard rhythm for a US equity fund.

• SEIV 0.15% a year for genuine active selection, against a 0.55% median in its U.S. value peer group. It matches the cheapest large-value quant funds rather than charging active prices.
• Value is not the only screen. The model also weighs quality, momentum and low volatility, which is how a cheap-stock strategy tries to avoid the cheap-for-a-reason trap.
• Other funds measured against the S&P 500 in this cohort charge far more (LSVD 0.40%, GSPY 0.50%, VNSE 1.34%). SEIV runs its version at 0.15%.
• Sits among the strongest implementations in a crowded U.S. value field, and trades with enough regular activity to be workable for ordinary retail order sizes.

Worth knowing

• GMOV Thinly traded and modest in size, so spreads can be wide. Limit orders matter more here than with a mega-fund.
• Systematic value rivals cost far less: AVLV and SEIV run 0.15%, DFLV 0.21%. You are paying up for human-plus-model stock selection.
• Live since October 2024, so risk and behavior can only be read off about a year of trading, not a full cycle.

• SEIV About 80 stocks measured against a 500-name benchmark. That concentration means stretches where it looks nothing like the S&P 500, in either direction.
• Launched in 2022, so the live record is short, and the asset base is mid-sized rather than among the giants of the value aisle.
• You get the factor recipe, not the trade-by-trade logic: selection sits inside a quantitative model. Distributions land quarterly, not monthly.

Full GMOV profile⁠

Full SEIV profile⁠